Apimeds Pharmaceuticals US (APUS) EPS (2024 - 2026)
Apimeds Pharmaceuticals US (APUS) EPS from Mar 31, 2024 to Mar 31, 2026. The TTM Apimeds Pharmaceuticals US (APUS) EPS is -$3.23. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Apimeds Pharmaceuticals US (APUS) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +1615.05% |
Annual EPS change of Apimeds Pharmaceuticals US (APUS)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$2.79 | +267.25% |
| 2025 | -$0.76 | +331.65% |
| 2024 | -$0.18 | +78.21% |
| 2023 | -$0.10 | N/A |